OTCMKTS:ERBA - ERBA Diagnostics Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.22 0.00 (0.00 %)
(As of 05/22/2019 02:34 PM ET)
Previous Close$0.22
Today's Range$0.22 - $0.2420
52-Week Range$0.1410 - $0.53
Volume10,000 shs
Average Volume13,306 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta1.77
ERBA Diagnostics, Inc., through its subsidiaries, develops, manufactures, and markets diagnostic test kits or assays, and automated systems that are used to aid in the detection of disease markers primarily in the areas of autoimmune, infectious diseases, clinical chemistry, hematology, and diabetes testing. It manufactures scientific and laboratory instruments, such as Mago 4, Mago 4S, and Mago Plus systems, which perform tests in an automated mode; sells other diagnostic products manufactured by third parties in Italy; and develops, manufactures, and markets raw materials, such as antigens that are used in the production of diagnostic kits. The company also develops, manufactures, and markets autoimmune reagents and research products for use by research laboratories and commercial diagnostic manufacturers. In addition, the company provides instruments for blood cell counting and blood analysis; supplies reagents and other consumable materials; sells diabetic testing products, including the DS5 instrument, dispenser, and associated reagent kits, which measure long-term glucose control in diabetic patients; and offers equipment for use in the field of human and veterinary hematology. Further, it manufactures and sells liquid stable, diagnostics chemistry reagents used for in vitro diagnostics testing. The company markets its products through its sales force to hospitals, reference laboratories, clinical laboratories, and research laboratories, as well as to other commercial companies that manufacture diagnostic products in the United States; and through sales representatives and independent agents in Italy, as well as through independent distributors internationally. The company was founded in 1980 and is headquartered in Miami Lakes, Florida. ERBA Diagnostics, Inc. is a subsidiary of ERBA Diagnostics Mannheim GmbH.

Receive ERBA News and Ratings via Email

Sign-up to receive the latest news and ratings for ERBA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ERBA
Previous SymbolNYSEMKT:ERB
CUSIPN/A
Phone305-324-2300

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

ERBA Diagnostics (OTCMKTS:ERBA) Frequently Asked Questions

What is ERBA Diagnostics' stock symbol?

ERBA Diagnostics trades on the OTCMKTS under the ticker symbol "ERBA."

Has ERBA Diagnostics been receiving favorable news coverage?

Headlines about ERBA stock have been trending somewhat negative recently, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. ERBA Diagnostics earned a news sentiment score of -1.9 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the next several days.

Who are some of ERBA Diagnostics' key competitors?

What other stocks do shareholders of ERBA Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ERBA Diagnostics investors own include Ekf Diagnostics (EKF), Synergy Pharmaceuticals (SGYP), Attunity (ATTU), ContraFect (CFRX), Catalyst Pharmaceuticals (CPRX), ImmunoGen (IMGN), IQIYI (IQ), Myriad Genetics (MYGN), Nektar Therapeutics (NKTR) and OHR Pharmaceutical (OHRP).

Who are ERBA Diagnostics' key executives?

ERBA Diagnostics' management team includes the folowing people:
  • Mr. Suresh Vazirani, Exec. Chairman & MD (Age 69)
  • Mr. David Barka, Interim Chief Exec. Officer (Age 38)
  • Mr. Nate Wells, Chief Financial Officer
  • Dr. Chandra Krishnan, Sr. VP of Global Sales, Marketing and Bus. Devel.

How do I buy shares of ERBA Diagnostics?

Shares of ERBA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ERBA Diagnostics' stock price today?

One share of ERBA stock can currently be purchased for approximately $0.22.

What is ERBA Diagnostics' official website?

The official website for ERBA Diagnostics is http://www.erbadiagnostics.com/.

How can I contact ERBA Diagnostics?

ERBA Diagnostics' mailing address is 14100 Nw 57th Court, Miami Lakes FL, 33014. The company can be reached via phone at 305-324-2300 or via email at [email protected]


MarketBeat Community Rating for ERBA Diagnostics (OTCMKTS ERBA)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  60 (Vote Outperform)
Underperform Votes:  61 (Vote Underperform)
Total Votes:  121
MarketBeat's community ratings are surveys of what our community members think about ERBA Diagnostics and other stocks. Vote "Outperform" if you believe ERBA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ERBA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel